Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeff Albrecht

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Psychoactive Drugs|February 5, 2025
Tripping into Treatment: Comparing Initial and Current Motivations for Psychedelic UseDaniel J Kruger, Jeff Albrecht, Jacob S Aday, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
Changes in the presence of multiple markers of circulating melanoma cells correlate with clinical outcome in patients with melanomaSandra R Reynolds, Jeff Albrecht, Richard L Shapiro, et al.
Antiviral Therapy|July 26, 2005
The clinical utility of using Catrimox-14-treated whole blood in detecting hepatitis C virus RNAKeyur Patel, Jeff Albrecht, Erin Owens, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 13, 2002
Induction of IL-1Ra in resistant and responsive hepatitis C patients following treatment with IFN-con1Scott J Cotler, Teresa Craft, Mary Ferris, et al.
Hepatology (Baltimore, Md.)|August 8, 2014
Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modelingJeremie Guedj, Yaron Rotman, Scott J Cotler, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Psychoactive Drugs|February 5, 2025
Tripping into Treatment: Comparing Initial and Current Motivations for Psychedelic UseDaniel J Kruger, Jeff Albrecht, Jacob S Aday, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2003
Changes in the presence of multiple markers of circulating melanoma cells correlate with clinical outcome in patients with melanomaSandra R Reynolds, Jeff Albrecht, Richard L Shapiro, et al.
Antiviral Therapy|July 26, 2005
The clinical utility of using Catrimox-14-treated whole blood in detecting hepatitis C virus RNAKeyur Patel, Jeff Albrecht, Erin Owens, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 13, 2002
Induction of IL-1Ra in resistant and responsive hepatitis C patients following treatment with IFN-con1Scott J Cotler, Teresa Craft, Mary Ferris, et al.
Hepatology (Baltimore, Md.)|August 8, 2014
Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon-alpha therapy via mathematical modelingJeremie Guedj, Yaron Rotman, Scott J Cotler, et al.
Pageof 1